@Fenng: The promoter of the randomized double-blind principle: C.C. Li, a Chinese-American biostatistician. In the mid-1950s, in a large-scale multicenter cancer drug clinical trial at the US Veterans Hospital, he overruled objections and forcefully implemented the principles of "random allocation" and "double-blind", greatly promoting the popularization of double-blind methods in large clinical trials...
Summary
Introducing the Chinese-American biostatistician C.C. Li, who in the 1950s promoted the popularization and standardization of the randomized double-blind principle in large-scale cancer drug clinical trials, making significant contributions to modern clinical trial methodology.
View Cached Full Text
Cached at: 05/18/26, 12:24 AM
The Promoter of Randomized Double-Blind Principles: C.C. Li
A Chinese-American biostatistician. In the mid-1950s, during a large-scale multicenter cancer drug trial at a U.S. Veterans Administration hospital, he insisted on enforcing the principles of “random assignment” and “double-blinding” despite strong opposition, greatly advancing the adoption and standardization of the double-blind method in large clinical trials.
This contribution was also significant.
Similar Articles
@Fenng: https://x.com/Fenng/status/2062442498308624715
The article recounts how ByteDance founder Zhang Yiming originally applied to study biology in the college entrance exam but was not admitted, and ended up in software engineering by a twist of fate. It also touches on the influence the book *General Biology* had on him, reflecting on the quirks of history and the randomness of individual destiny.
LingxiDiagBench: A Multi-Agent Framework for Benchmarking LLMs in Chinese Psychiatric Consultation and Diagnosis
Introduces LingxiDiagBench, a large-scale multi-agent benchmark for evaluating LLMs on Chinese psychiatric consultation and diagnosis. Key findings show high accuracy on binary classification but poor performance on multi-way differential diagnosis, highlighting a decoupling between conversational quality and diagnostic accuracy.
iLENS: Interpretable LLM-Guided Mixture-of-Experts for Neuroimaging Survival Analysis
This paper introduces iLENS, an interpretable LLM-guided mixture-of-experts framework for survival prediction and patient subtyping in Alzheimer's disease using neuroimaging data. The approach provides transparent, biologically grounded rationales for its routing decisions, bridging high-performance survival analysis with interpretable clinical decision support.
@liuren: https://x.com/liuren/status/2069266318747165146
This article recounts in detail the story of Jia Yangqing developing the deep learning framework Caffe (originally named Decaf) from scratch during his time at Berkeley and choosing to open-source it, as well as his personal growth from a student to a technical leader.
@Xudong07452910: This latest AutoScientists paper from Harvard is worth reading. It makes me think that AI doing research might not move toward "a single super AI scientist handling the entire process," but rather more like an AI lab that organizes itself. The core of this paper is: allowing multiple agents to share experimental status, organizing around...
Harvard University's AutoScientists proposes a decentralized multi-agent team approach, allowing multiple agents to share experimental status, automatically form teams, and review research plans, significantly outperforming existing methods on multiple benchmarks.